Results 11 to 20 of about 685,742 (313)

Is There (Still) a Place for Sequential Conditioning?

Current Oncology
There is still an unmet need for the treatment of high-risk hematological malignancies. To date, allogeneic stem cell transplantation remains the only chance of cure.
Boris Bours, Stavroula Masouridi-Levrat
doaj   +2 more sources

Oxyfertigation and Transplanting Conditions of Strawberries [PDF]

Agronomy, 2021
Soilless growing systems can improve water-use efficiency, especially in closed soilless growing systems. The main purpose of this study was to evaluate the effects of different transplanting conditions, and determine how supplying H2O2 as an oxygen source to the rhizosphere of strawberry plants in a soilless growing system affects plant growth, fruit ...
Pedro Palencia, Fátima Martínez, Miguel A. Vázquez   +2 more
openaire   +4 more sources

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation [PDF]

Blood, 2022
Abstract The intensity of the conditioning regimen given before allogeneic hematopoietic cell transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently developed transplant conditioning intensity (TCI) score to stratify the preparative regimens of allo-HCT, we used an independent and contemporary patient cohort ...
Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles Craddock, Eva Maria Wagner-Drouet, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald. G. Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus Kröger, Victoria Potter, Edouard Forcade, Jakob Passweg, Régis Peffault de Latour, Johan Maertens, Keith M. O. Wilson, Jean Henri Bourhis, Juergen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin P. Savani, Arnon Nagler, Fabio Ciceri, Mohamad Mohty   +29 more
openaire   +9 more sources

Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma [PDF]

, 2022
Conditioning with treosulfan and fludarabine (Treo/Flu) has been proven to be feasible and efficient in several types of malignancies before allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Scholl, Sebastian, Miethke, Jenny, Schnetzke, Ulf, Frietsch, Jochen J., Hochhaus, Andreas, Hilgendorf, Inken, Crodel, Carl C., Linke, Paul, Sebastian Scholl, Jenny Miethke, Paul Linke, Carl C. Crodel, Inken Hilgendorf, Ulf Schnetzke, Jochen J. Frietsch, Andreas Hochhaus   +15 more
core   +1 more source

Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation [PDF]

, 2023
: For acute lymphoblastic leukemia (ALL) patients, total body irradiation (TBI)- based conditioning regimens are the first choice specially in young population.
Sestili, Simona, Banet, Anne, Labopin, Myriam, Genthon, Alexis, Memoli, Mara, Legrand, Ollivier, Belhocine, Ramdane, Duléry, Rémy, Bazarbachi, Ali Abdul Hamid, Ledraa, Tounes, Bazarbachi, Ali, Malard, Florent, Bonnin, Agnes, Mohty, Mohamad, Brissot, Eolia, El-Cheikh, Jean, Van de Wyngaert, Zoé, Stocker, Nicolas   +17 more
core   +1 more source

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]

, 2004
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J   +37 more
core   +1 more source

To condition or not to condition—That is the question: The evolution of nonmyeloablative conditions for transplantation [PDF]

Experimental Hematology, 2016
In 1985, Eugene Cronkite and his colleagues published, in Experimental Hematology, data indicating that five consecutive "transfusions" of large numbers of marrow cells significantly increase the number of donor-derived cells detected by day 10 of a spleen colony-forming assay, the most primitive hematopoietic cells detectable at that time, present in ...
openaire   +2 more sources

Ischemic Conditioning in Kidney Transplantation

Journal of Cardiovascular Pharmacology and Therapeutics, 2017
Ischemia–reperfusion injury is a composite of the injury sustained during a period of reduced or absent blood flow to a tissue or organ and the additional insult sustained on reperfusion, which limits the amount of tissue that can be salvaged. Ischemia–reperfusion injury is the predominant insult during kidney transplantation, contributing to graft ...
Veighey, K, MacAllister, R
openaire   +3 more sources

CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAIN [PDF]

Journal of Experimental Medicine, 1923
In confirmation of Shirai's observation, we find that transplantable mouse tumors grow actively when inoculated into the brains of rats, guinea pigs, and pigeons, whereas subcutaneous or intramuscular grafts in the same animals fail. This growth of foreign tissue in the brain, however, takes place only when the grafted material lies entirely in the ...
J B, Murphy, E, Sturm
openaire   +2 more sources

Difficult Vascular Conditions in Kidney Transplantation

Transplantation Proceedings, 2006
The new dialytic and medical therapies have improved the survival of uremic patients and their preservation of a efficacious clinical condition so as to warrant suitability for transplantation, even after a long period of dialysis. In addition, today the use of a "marginal donor" and "marginal kidney" are often used to increase the pool of available ...
P. De Rosa, SANTANGELO, MICHELE, A. Scala, D.M. Vallefuoco, L. Caggiano, IMBRIACO, MASSIMO, G. Spinosa   +6 more
openaire   +5 more sources